Aya Biosciences
La Jolla, US · Founded 2020 · Delaware corporation
Founders & leadership
MA
Micah AndersonNamed on SEC filing
WA
Wajdie AhmadNamed on SEC filing
DP
Del PotterNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$5M disclosed across 1 round · 2020
▶$5MraisedJun 2021 · 14 investors · PharmaceuticalsRule 506(b)
▶$5MraisedJun 2021 · 14 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Micah AndersonExecutive Officer, Director
- Wajdie AhmadDirector
- Del PotterDirector
- Offering amount
- $5M
- Amount sold
- $5M
- Minimum investment
- $5K
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Aya Biosciences raised?
- Aya Biosciences has disclosed $5M raised across 1 round.
- Where is Aya Biosciences headquartered?
- Aya Biosciences is headquartered in La Jolla, US.